Agenus Inc/ US00847G8042 /
2024-04-24 10:00:00 PM | Chg. +0.9600 | Volume | Bid1:37:22 AM | Ask1:37:22 AM | High | Low |
---|---|---|---|---|---|---|
7.4200USD | +14.86% | 1.27 mill. Turnover: 7.62 mill. |
7.3000Bid Size: 1,200 | 7.4200Ask Size: 1,000 | 7.7400 | 6.3100 |
GlobeNewswire
04-08
MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liv...
GlobeNewswire
03-06
MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Meta...
GlobeNewswire
02-14
First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allo...
GlobeNewswire
01-18
Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic...
GlobeNewswire
01-03
Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer
GlobeNewswire
2023-11-03
MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in S...
GlobeNewswire
2023-10-11
Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The O...
GlobeNewswire
2023-08-31
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
GlobeNewswire
2022-03-07
Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 S...
GlobeNewswire
2022-02-22
Sigilon Therapeutics Appoints Sarah Yuan, Ph.D., as Chief Technical Operations Officer
GlobeNewswire
2022-02-22
Oncorus Announces Promotion of John Goldberg, M.D. to Chief Medical Officer
GlobeNewswire
2022-02-15
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
GlobeNewswire
2021-12-22
Balstilimab Plus Zalifrelimab Data Published in Journal of Clinical Oncology (JCO)
GlobeNewswire
2021-11-12
Clinical Activity of AGEN1181 Demonstrated Across Nine Treatment-Resistant Cancers at SITC
GlobeNewswire
2021-11-12
MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failur...
GlobeNewswire
2021-11-09
MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2...
GlobeNewswire
2021-11-09
Agenus to Participate in Fireside Chat at the B. Riley Fall 2021 Growth Biotech Best Ideas Series